TFX
Teleflex Incorporated124.87
-1.85-1.46%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
5.52BP/E (TTM)
-Basic EPS (TTM)
-7.17Dividend Yield
0.01%Recent Filings
8-K
8-K
10-Q
10-Q
Q2 FY2025 results
Teleflex posted solid Q2 momentum, with net revenues climbing 4.2% year-over-year to $780.9 million, fueled by new product gains and favorable currency shifts, though YTD revenues dipped 0.4% to $1,481.6 million amid OEM and UroLift softness. Gross margins held at 55.2%, down 0.4 points y/y from cost pressures, while operating income surged 33% y/y to $155.3 million, boosted by $59.7 million in foreign exchange gains from VI acquisition hedges; diluted EPS rose to $2.77 from $1.69. Cash from operations fell to $81.2 million YTD, with free cash flow at $16.5 million (derived) after $64.6 million capex, and total debt stood at $1.9 billion including $370.1 million revolver draw. The VI deal closed June 30 for €704.3 million cash, adding stents and balloons via $700 million delayed term loan, while separation costs for a potential NewCo spin hit $12.9 million. Yet regulatory pricing in Italy poses a lingering drag.
8-K
Teleflex Q2 beats, raises outlook
Teleflex reported Q2 revenue of $780.9 million, up 4.2% year-over-year, with adjusted constant currency growth of 1.0%, fueled by 19.3% interventional gains yet offset by anesthesia and OEM declines. The company closed its €704 million acquisition of BIOTRONIK's Vascular Intervention business on June 30, bolstering cath lab presence and peripheral market entry. It raised 2025 guidance to 7.7-8.7% adjusted constant currency revenue growth and $13.90-$14.30 adjusted EPS. Integration risks loom large.
IPO
Website
Employees
Sector
Industry
AVTR
Avantor, Inc.
11.20-0.08
BAX
Baxter International Inc.
19.05-0.48
BDX
Becton, Dickinson and Company
196.39-3.70
BSX
Boston Scientific Corporation
92.95+0.76
ICUI
ICU Medical, Inc.
147.07-0.96
LMAT
LeMaitre Vascular, Inc.
83.41+0.64
MBOT
Microbot Medical Inc.
2.22+0.01
MMSI
Merit Medical Systems, Inc.
86.85+0.44
SYK
Stryker Corporation
351.69-3.62
UTMD
Utah Medical Products, Inc.
58.43+0.94